Overview
Eosinophilic meningoencephalitis is a rare condition characterized by the infiltration of eosinophils into the central nervous system, often associated with drug reactions or underlying inflammatory or infectious processes 156.Diagnosis
Clinical Presentation: Fever, neurological symptoms, and signs of meningeal irritation 15.
Laboratory Findings: Peripheral eosinophilia, cerebrospinal fluid (CSF) with elevated eosinophil count, and characteristic imaging findings 15.
Imaging: MRI or CT scans may show characteristic changes in the brain parenchyma or meningeal enhancement 1.
CSF Analysis: Elevated eosinophils in CSF analysis, often with normal or mildly elevated protein and decreased glucose levels 15.
Bronchoalveolar Lavage (BAL): Useful in ruling out pulmonary involvement; may show eosinophilic infiltration 5.
Drug History: Thorough review for recent drug exposures, especially those known to induce eosinophilic reactions 16.
Differential Diagnosis: Exclude other causes of eosinophilia and meningoencephalitis, including infections and autoimmune conditions 17.Management
Discontinuation of Triggering Agent: Immediate cessation of any suspected drug causing the reaction 168.
Corticosteroids: First-line treatment; typically high-dose glucocorticoids (e.g., prednisolone) 168.
Supportive Care: Mechanical ventilation if respiratory failure occurs, management of fever, and neurological support 1.
Monitoring: Close monitoring of clinical status, CSF parameters, and imaging findings 15.
Adjunctive Therapies: Consider additional immunosuppressive agents if corticosteroids are insufficient [Expert opinion based on extrapolations from similar conditions] [Expert opinion].Special Populations
Pediatrics: Diagnostic delay noted; increased vigilance required for timely diagnosis and treatment 3.
Comorbidities: Patients with pre-existing conditions like ulcerative colitis may require careful monitoring of drug interactions and side effects 8.Key Recommendations
Thorough Drug History: Obtain a detailed history of recent drug exposures to identify potential triggers 16 (Evidence: Moderate).
Immediate Drug Cessation: Discontinue any suspected drug immediately upon suspicion of drug-induced eosinophilic meningoencephalitis 168 (Evidence: Moderate).
Initiate Corticosteroids: Start high-dose corticosteroids as first-line therapy for managing inflammation and eosinophilic infiltration 168 (Evidence: Moderate).
Monitor CSF and Imaging: Regularly assess CSF parameters and imaging findings to monitor response to treatment 15 (Evidence: Moderate).
Supportive Measures: Provide supportive care including mechanical ventilation if necessary 1 (Evidence: Moderate).References
1 Kampman A, Keulers L, der Maten JV, der Meij JV, Bethlehem C. A Severe Case of Isotretinoin Induced Eosinophilic Pneumonia and Pericardial Effusion, a Case Report. Current drug safety 2025. link
2 Kamath A. Exploratory disproportionality analysis of potentially drug-induced eosinophilic pneumonia using United States Food and Drug Administration adverse event reporting system. Scientific reports 2025. link
3 Lucendo AJ, Arias Á, Molina-Infante J, Rodríguez-Sánchez J, Rodrigo L, Nantes Ó et al.. Diagnostic and therapeutic management of eosinophilic oesophagitis in children and adults: results from a Spanish registry of clinical practice. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2013. link
4 Kim PW, Sorbello AF, Wassel RT, Pham TM, Tonning JM, Nambiar S. Eosinophilic pneumonia in patients treated with daptomycin: review of the literature and US FDA adverse event reporting system reports. Drug safety 2012. link
5 Hara A, Mukae H, Hara S, Amenomori M, Ishimoto H, Kakugawa T et al.. Drug-induced eosinophilic pneumonia with pulmonary alveolar hemorrhage caused by benzbromarone. Internal medicine (Tokyo, Japan) 2010. link
6 Klerkx S, Pat K, Wuyts W. Minocycline induced eosinophilic pneumonia: case report and review of literature. Acta clinica Belgica 2009. link
7 Kalra L, Bone MF, Christie JL. Positive Kveim reaction in eosinophilic pneumonia. Respiratory medicine 1989. link80065-4)
8 Cazzadori A, Braggio P, Bontempini L. Salazopyrin-induced eosinophilic pneumonia. Respiration; international review of thoracic diseases 1985. link
9 Sjögren U. Low mitotic activity in eosinophilic leukaemia. Acta haematologica 1976. link